- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02081482
Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation (MET-ONS)
Study of the Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation
The occipital nerve stimulation (ONS) is used to treat patients with refractory primary chronic headache but its mechanism of action (MoA) remains unknown. Different hypothesis have been suggested in particular a specific action on cerebral generators involved in different types of primary headaches or a non specific action on pain modulatory network.
The aim of this study, using the chronic cluster headache as a model, is to determine the changes in cerebral metabolism induced by ONS to precise its MoA in the treatment of primary chronic headache.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont Ferrand, France, 63000
- CHU -Hôpital Gabriel Montpied
-
Marseille, France, 13385
- Institut des Neurosciences
-
Nice, France, 06000
- Département d'Evaluation et Traitement de la Douleur - Pôle Neurosciences Cliniques - Centre Hospitalo-Universitaire de Nice
-
Paris, France, 75010
- Centre d'Urgence Céphalées
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age > 18 years
- chronic cluster headache (according to the IHS)
- refractory in who a treatment by ONS have been indicated
- patient affiliated at social security,
- informed consent signed
Exclusion Criteria:
- contraindication to MRI
- contraindication to 18F-FDG PET
- women without contraception/pregnant/breast-feeding
- patient non-compliant
- patient on legal guardianship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: subjects with refractory chronic cluster headache
Adult subjects with refractory chronic cluster headache and ONS indication
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of cerebral metabolism
Time Frame: Baseline (before ONS), 1 week after ONS , 3 month after ONS
|
Changes of cerebral metabolism associated with ONS efficacy
|
Baseline (before ONS), 1 week after ONS , 3 month after ONS
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-AOI-05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractory Chronic Cluster Headache
-
University Hospital, Clermont-FerrandInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingRefractory Chronic Cluster HeadacheFrance
-
Diamond Headache ClinicGlaxoSmithKlineUnknownEpisodic Cluster Headache | Chronic Cluster HeadacheUnited States
-
Eli Lilly and CompanyCompletedEpisodic Cluster Headache | Chronic Cluster HeadacheSpain, United States, Finland, Germany, United Kingdom, Belgium, France, Denmark, Italy, Netherlands, Canada, Greece
-
Man and Science, SARecruitingChronic Cluster HeadacheBelgium
-
Radboud University Medical CenterLeiden University Medical Center; ZonMw: The Netherlands Organisation for Health... and other collaboratorsNot yet recruitingChronic Cluster Headache
-
Leiden University Medical CenterUniversity of Copenhagen; Maastricht University Medical Center; Erasmus Medical... and other collaboratorsCompletedChronic Cluster HeadacheNetherlands, Belgium, Germany, Hungary
-
Salvia BioElectronicsRecruitingChronic Cluster HeadacheAustralia
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Cluster HeadacheUnited States, Australia, Canada, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
-
Eli Lilly and CompanyCompletedChronic Cluster HeadacheUnited States, Germany, France, Canada, Belgium, Denmark, Finland, Greece, Italy, Netherlands, Spain, United Kingdom
-
University of Roma La SapienzaCompletedChronic Cluster HeadacheItaly
Clinical Trials on 18F-FDG PET
-
Tim LauMcGill UniversityNot yet recruitingCognitive Impairment | Dementia | Dementia With Lewy Bodies
-
Hospices Civils de LyonCompleted
-
National Cancer Institute (NCI)CompletedNeurofibromatosis | MPNSTUnited States
-
University of UtahCompleted
-
Universität Duisburg-EssenCrohn's and Colitis FoundationCompleted
-
Peking University Cancer Hospital & InstituteUnknownLymphoma | Positron-Emission Tomography | Tumor, SolidChina
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University Hospital, GhentCompletedA Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck CancerSquamous Cell CarcinomaBelgium
-
Ohio State University Comprehensive Cancer CenterCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States